Functional Nano-Scaffolds for Regenerative Medicine PhD programme

nanoremedi
Funding Program
EU - Horizon Europe
Coordinator
University of Milano
Call
MSCA
Project ID
101072645
PI at nanoGUNE
Alexander Bittner
From
To
Contribution to nanoGUNE
396.302,4€
Research group

The mission of NanoReMedi is to define a joint doctorate educational training model in Functional Nano-Scaffolds for Regenerative Medicine where Academia and Industry join their forces to create a highly innovative research network for training a new generation of researchers who will enter the area of nanoscience from adjacent disciplines (such as chemistry, material sciences and bioinformatics) establish a solid framework for long-term research cooperation between a pool of leading Universities and Enterprises build a solid foundation for long-term European excellence in medical nanotechnology. 

NanoReMedi main tasks are:

  • to train 13 ESRs in a joint academic / industrial programme of cutting-edge training-by-research, high quality supervision, complementary and transferable skills, inter-network secondments, and workshops or Summer Schools 
  • to pursue an innovative research project on regenerative medicine that will tackle highly relevant case studies: “Tissue engineered vascular grafts to replace damaged peripheral arteries”, “Stem-cell based regenerative medicine for bone and cartilage repair” and “Facing with implantation. 
  • to transfer expertise/know-how among the Consortium participants and to external groups via networking activities, intersectoral exposure, secondments, workshops, sharing of learning material, public engagement and outreach activities

Upon completion of the programme, graduates will become highly skilled researchers and professionals in the field of nanomaterials applied to regenerative nanomedicine, matching the requirements of both public and private sectors. 

The breadth and depth of the programme will prepare PhD students for a wide range of career opportunities. Graduates will find opportunities in universities, public and private research centers, hospitals, public administration, government agencies and international organizations. They could join dynamic positions in pharmaceutical and biotechnology engineering companies. 

 

Keywords